Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294
주식 순위
#3418
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
주가
$4.48
시가총액
$4.99B
변동 (1일)
-5.20%
변동 (1년)
-41.89%
국가
CN
거래 Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
카테고리
Healthcare
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)의 배당 이력
Shenzhen Salubris Pharmaceuticals Co., Ltd. (주식 심볼: 002294)은 총 16회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): $7.30
배당 수익률 (TTM): 0.0184
모든 배당금의 합계 (주식 분할 반영): $7.30
배당 수익률 (TTM): 0.0184
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)의 2010부터 2026까지 배당 지급 내역
연간 배당 지급
| 연도 | 배당금 (주식 분할 조정됨) | 변화 |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | 37.14% |
| 2015 | $0.4375 | 16.67% |
| 2014 | $0.375 | 28.56% |
| 2013 | $0.2917 | 86.63% |
| 2012 | $0.1563 | 20.05% |
| 2011 | $0.1302 | 139.78% |
| 2010 | $0.0543 | 0.00% |
모든 배당 지급 목록
| 연도 | 배당금 | 변화 |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | -14.29% |
| 2015 | $0.7 | 16.67% |
| 2014 | $0.6 | -14.29% |
| 2013 | $0.7 | 55.56% |
| 2012 | $0.45 | -25.00% |
| 2011 | $0.6 | 20.00% |
| 2010 | $0.5 | 0.00% |
유사 기업 또는 경쟁사의 배당 지급
| 회사 | 배당 지급 횟수 | 국가 |
|---|---|---|
| 0.00% |
US
|
|
| 27.00% |
FR
|
|
| 52.00% |
JP
|
|
| 175.00% |
US
|
|
| 7.00% |
CH
|
